CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: Common co-signals induced by CD80 and CD86

被引:22
|
作者
Cefai, D
Cai, YC
Hu, H
Rudd, C
机构
[1] DANA FARBER CANC INST, DIV TUMOR IMMUNOL, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA
关键词
D O I
10.1093/intimm/8.10.1609
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD80 (B7-1) and CD86 (B7-2) ligation of CD28 provide co-stimulatory signals required for optimal lymphokine production in response to TCR zeta-CD3 ligation, CD28 binds to several intracellular proteins including phosphatidylinositol 3-kinase (PI3-kinase), the tyrosine kinase ITK and the growth factor receptor-bound protein/Son of Sevenless (GRB-2/SOS) complex, Previously, we showed that TCR zeta-CD3 and CD28 co-stimulation required PI3-kinase binding to the pYMNM motif of the cytoplasmic domain of the co-receptor, In this study, we have investigated whether CD28-associated PI3-kinase is required for CD80 and CD86 co-stimulation, as well as in co-signaling that involves different primary signals (i.e. TCR zeta-CD3 versus phorbol ester/ionomycin), In the presence of anti-CD3, ligation of CD28 by both CD80 and CD86 was found to induce PI3-kinase recruitment and IL-2 production, Furthermore, mutations at Y-191 and M-194 within the pYMNM motif blocked the ability of both ligands to induce IL-2, CD80 and CD86 therefore share a common signaling pathway leading to IL-2 production. By contrast, CD28 mediated co-stimulation involving receptor ligation plus phorbol ester/ionomycin induced IL-2 independent of PI3-kinase binding to CD28, These data indicate that TCR zeta-CD3-dependent CD80 and CD86 co-signaling requires PI3-kinase binding to the CD28pYMNM motif, while phorbol ester and ionomycin can bypass this requirement in CD28 co-stimulation.
引用
收藏
页码:1609 / 1616
页数:8
相关论文
共 50 条
  • [31] Development of Novel Monoclonal Antibodies for the Robust Detection of CD28, CD80 and CD86 by Immunohistochemistry in Human Tumors
    Means, Gary
    Sanderson, Russell
    Johnson, Brian
    Larmore, Megan
    Maurer, Mark
    Peng, Stanford
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1704 - 1705
  • [32] Tasmanian devil CD28 and CTLA4 capture CD80 and CD86 from adjacent cells
    Wong, Candida
    Darby, Jocelyn M.
    Murphy, Peter R.
    Pinfold, Terry L.
    Lennard, Patrick R.
    Woods, Gregory M.
    Lyons, A. Bruce
    Flies, Andrew S.
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2021, 115
  • [33] Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function
    Kariv, I
    Truneh, A
    Sweet, RW
    JOURNAL OF IMMUNOLOGY, 1996, 157 (01): : 29 - 38
  • [34] Differential effects of iron deficiency on the expression of CD80 and CD86 co-stimulatory receptors in mitogen-treated and untreated murine spleen cells
    Kuvibidila, SR
    Porretta, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 86 (03) : 571 - 582
  • [35] Co-stimulatory blockade of the CD28/CD80-86/CTLA-4 balance in transplantation: impact on memory T cells?
    Ville, Simon
    Poirier, Nicolas
    Blancho, Gilles
    Vanhove, Bernard
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [36] Expression of the costimulator molecules, CD80, CD86, CD28, and CD152 on lymphocytes from neonates and young children
    Elliott, SR
    Macardle, PJ
    Roberton, DM
    Zola, H
    HUMAN IMMUNOLOGY, 1999, 60 (11) : 1039 - 1048
  • [37] Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma
    Wong, CK
    Lun, SWM
    Ko, FWS
    Ip, WK
    Hui, DSC
    Lam, CWK
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 141 (01): : 122 - 129
  • [38] Neuroblastoma cells transiently transfected to simultaneously express the co-stimulatory molecules CD54, CD80, CD86, and CD137L generate antitumor immunity in mice
    Johnson, BD
    Gershan, JA
    Natalia, N
    Zujewski, H
    Weber, JJ
    Yan, XC
    Orentas, RJ
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (05) : 449 - 460
  • [39] Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28
    Metzler, WJ
    Bajorath, J
    Fenderson, W
    Shaw, SY
    Constantine, KL
    Naemura, J
    Leytze, G
    Peach, RJ
    Lavoie, TB
    Mueller, L
    Linsley, PS
    NATURE STRUCTURAL BIOLOGY, 1997, 4 (07) : 527 - 531
  • [40] Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86
    Manzotti, CN
    Liu, M
    Burke, F
    Dussably, L
    Zheng, Y
    Sansom, DM
    IMMUNOLOGY, 2005, 116 : 6 - 6